MedPath

To find out the required level of Oxygen for respiratory care of premature babies at the time of delivery and to check its effect on babys development.

Phase 3
Conditions
Health Condition 1: null- Neonates/ Premature Babies
Registration Number
CTRI/2017/05/008517
Lead Sponsor
The University of Sydney represented by and acting through the NHMRC Clinical Trials Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
1200
Inclusion Criteria

1)Premature infants from 23+0 weeks to 28+6 weeks Gestational Age.

2)Signed written informed consent by parents(s) or legal guardian(s)

Exclusion Criteria

1)Any known major cardio pulmonary abnormalities that could affect oxygenation or co-genital malformitions that could affect neurodevelopmental outcomes.

2) Anticipated inability to follow up for two years, e.g. Parents normally resident overseas in an inaccessible location.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath